Replies to post #3670 on NorthWest Biotherapeutics Inc (NWBO)

[john1045]

Notice the second paragraph from their web site on ...new generation dendritic cells

Researchers have shown that fresh and vital dendritic cells can be introduced into the body in the form of a vaccine. If cancer is present, inoculation with new dendritic cells alerts the immune system to the presence of cancer and restarts proper immune function. This serves to mobilize the exceptional power of the immune system to identify cancer and combat it. These dendritic cells are cultured from the patient’s own white blood cells (so they are described as “autologous”).

Initially, after a simple blood draw, the blood is sent to a high-tech medical laboratory where specially trained cell biologists and technicians separate out certain white blood cells (monocytes) from the blood. These cells are then cultured and transformed in seven days into a new generation dendritic cells. This new generation of vital, activated dendritic cells is re-introduced into the patient’s body through simple intractaneous injections as shown above.

The results are remarkable by any standard, increasing immune response, patient survival, and quality of life.

I also noticed another use outside of solid tumor cancers on their site:

When we vaccinate for diseases such as tetanus or measles, the injection must be repeated five to six times at defined intervals, in order to establish life-long immunity. Vaccination improves specific immune function, but the immune system must be “trained” through repeated exposures. To improve immune function using dendritic cells, these new cells must be injected at least six times. Patients with all forms of cancer and also patients with chronic viral infections, such as Hepatitis B and C or HIV, are initially vaccinated with dendritic cells six times at monthly intervals.

Thereafter, the injections are repeated once every six months for the duration of three years as “booster shots” and then at usually yearly intervals. This ongoing dendritic cell vaccination is another aspect of treatment. Providing the vaccine on a schedule comparable to other vaccine protocols has resulted in an encouraging success rate of effective treatment. The importance of frequent vaccination in the initial stage of treatment has now been validated in scores of recent research studies.